| Tue 20 May 2008, 9:00 | | MYD - Myriad Medical Holdings Limited - Myriad med |
|
MYD
MYD
MYD - Myriad Medical Holdings Limited - Myriad medical expands product base with
three exclusive new agency agreements
MYRIAD MEDICAL HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 2006/006371/06)
Share code: MYD & ISIN: ZAE000085825
MYRIAD MEDICAL EXPANDS PRODUCT BASE WITH THREE EXCLUSIVE NEW AGENCY AGREEMENTS
Shareholders are advised that Myriad Medical Holdings (MYD) has secured three
new exclusive agency agreements with world class international players,
Uroplasty, Caldera Medical and Heinen & Lowenstein.
Uroplasty, a US-based, global, incontinence solution provider, has chosen to
shift from a long-standing, established South African agency distributor to
Myriad Medical. This agency allows Myriad to expand its product base and better
utilize its existing infrastructure.
California-based, Caldera Medical gives Myriad access to a raft of
differentiated, high-impact products across the Gynaecology, Urology, and
Urogynaecology specialties.
Furthermore, securing the agency for the provision of the Heinen & Lowenstein
products (neonatal intensive care and anaesthesia) also provides Myriad with
distribution rights for Heinen & Lowenstein`s much lauded anaesthesia machine -
first introduced to South Africa at the 14th World Congress of
Anaesthesiologists, held in Cape Town March 2008.
Myriad currently holds the exclusive South African agency rights to a further 27
leading organisations representing a wide range of premier international brands
that focus on the sophisticated, high-margin anaesthesia, surgical, cardiology
and critical care sectors of the South African medical devices industry.
Looking forward, the company will continue to pursue acquisitions and additional
agency opportunities that will enhance its substantial portfolio.
Enquiries:
Reuben Shapiro (Business Development Director)
Tel : +27 11 516 1742
Fax : +27 11 516 1745
Email : rshapiro@myriadmed.com
Johannesburg
20 May 2008
Designated Advisor
Sasfin Capital
(A division of Sasfin Bank Limited)
Date: 20/05/2008 09:00:01 Produced by the JSE SENS Department.
The SENS service is an information dissemination service administered by the
JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or
implicitly, represent, warrant or in any way guarantee the truth, accuracy or
completeness of the information published on SENS. The JSE, their officers,
employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature,
howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
